GPP
ACHV icon

Great Point Partners’s Achieve Life Sciences ACHV Stock Holding History

Great Point Partners’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-59
Closed -$1.53M – 39
2014
Q1 		$1.53M Buy
+59
New +$1.45M 0.8% 31

Other funds holding ACHV

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Great Point Partners's ACHV Position: Q4 2014 in Review

Great Point Partners sold out of Achieve Life Sciences (ACHV) in Q4 2014, closing a stake of 815 shares — an estimated $4.79M sold.

Great Point Partners first reported a position in ACHV in Q3 2013 and held it in 3 quarters. The position peaked at $7.88M in Q2 2014. 56 funds tracked by Wall St. Rank hold ACHV as of Q4 2014.

  • Great Point Partners reported no remaining Achieve Life Sciences position as of Q4 2014 after selling out during the quarter.
  • Great Point Partners sold 815 Achieve Life Sciences shares in Q4 2014, an estimated $4.79M.
  • Great Point Partners first reported a position in Achieve Life Sciences in Q3 2013 and held it in 3 quarters.
  • Great Point Partners's Achieve Life Sciences position peaked at $7.88M in Q2 2014.
  • 56 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2014.

Based on Great Point Partners's 13F filing for Q4 2014, filed 17 Feb 2015.